APA (7th ed.) Citation

McCarthy, C., Sacco, J., Fedele, S., Ho, M., Porter, S., Liloglou, T., . . . Shaw, R. (2021). SAVER: Sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. Trials, 22(1), 1. https://doi.org/10.1186/s13063-021-05373-8

Chicago Style (17th ed.) Citation

McCarthy, Caroline, et al. "SAVER: Sodium Valproate for the Epigenetic Reprogramming of High-risk Oral Epithelial Dysplasia-a Phase II Randomised Control Trial Study Protocol." Trials 22, no. 1 (2021): 1. https://doi.org/10.1186/s13063-021-05373-8.

MLA (9th ed.) Citation

McCarthy, Caroline, et al. "SAVER: Sodium Valproate for the Epigenetic Reprogramming of High-risk Oral Epithelial Dysplasia-a Phase II Randomised Control Trial Study Protocol." Trials, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s13063-021-05373-8.